BioCentury
ARTICLE | Company News

First Genetic Trust, GSK pharmacogenetics deal

October 10, 2001 7:00 AM UTC

First Genetic Trust (Chicago, Ill.) and GlaxoSmithKline (GSK; LSE:GSK) will study genetic variations associated with serious drug-related adverse reactions. GSK will sponsor the study and conduct all ...